Dimensional Fund Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,472,678
| Closed | -$7.6M | – | 3492 |
|
|
2019
Q2 | $7.6M | Buy |
1,472,678
+27,219
| +2% | +$122K | ﹤0.01% | 2491 |
|
|
2019
Q1 | $5.2M | Buy |
1,445,459
+212,240
| +17% | +$920K | ﹤0.01% | 2638 |
|
|
2018
Q4 | $7.56M | Buy |
1,233,219
+114,383
| +10% | +$698K | ﹤0.01% | 2461 |
|
|
2018
Q3 | $6.53M | Buy |
1,118,836
+208,508
| +23% | +$1.04M | ﹤0.01% | 2602 |
|
|
2018
Q2 | $3.87M | Buy |
910,328
+125,232
| +16% | +$631K | ﹤0.01% | 2731 |
|
|
2018
Q1 | $3.46M | Buy |
785,096
+183,294
| +30% | +$818K | ﹤0.01% | 2736 |
|
|
2017
Q4 | $3.17M | Buy |
601,802
+213,365
| +55% | +$1.31M | ﹤0.01% | 2757 |
|
|
2017
Q3 | $2.38M | Buy |
388,437
+7,542
| +2% | +$47.7K | ﹤0.01% | 2816 |
|
|
2017
Q2 | $2.75M | Buy |
380,895
+252,655
| +197% | +$1.55M | ﹤0.01% | 2775 |
|
|
2017
Q1 | $680K | Buy |
128,240
+59,181
| +86% | +$400K | ﹤0.01% | 3046 |
|
|
2016
Q4 | $496K | Buy |
69,059
+32,587
| +89% | +$263K | ﹤0.01% | 3090 |
|
|
2016
Q3 | $341K | Sell |
36,472
-7,611
| -17% | -$63.2K | ﹤0.01% | 3120 |
|
|
2016
Q2 | $279K | Sell |
44,083
-16,417
| -27% | -$106K | ﹤0.01% | 3133 |
|
|
2016
Q1 | $334K | Buy |
60,500
+16,300
| +37% | +$61.3K | ﹤0.01% | 3106 |
|
|
2015
Q4 | $247K | Buy |
+44,200
| New | +$292K | ﹤0.01% | 3188 |
|
|
2015
Q1 | – | Sell |
-1,000
| Closed | -$18K | – | 3429 |
|
|
2014
Q4 | $18K | Buy |
+1,000
| New | +$12.5K | ﹤0.01% | 3428 |
|
Other funds holding PETX
Dimensional Fund Advisors's PETX Position: Q3 2019 in Review
Dimensional Fund Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,472,678 shares — an estimated $7.6M sold.
Dimensional Fund Advisors first reported a position in PETX in Q4 2014 and held it in 16 quarters. The position peaked at $7.6M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Dimensional Fund Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,472,678 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $7.6M.
- Dimensional Fund Advisors first reported a position in Aratana Therapeutics, Inc. in Q4 2014 and held it in 16 quarters.
- Dimensional Fund Advisors's Aratana Therapeutics, Inc. position peaked at $7.6M in Q2 2019.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Dimensional Fund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.